CareFusion Signs Exclusive BlisPack(R) Distribution Agreement With Grifols to Help Improve Medication Safety in Hospitals

SAN DIEGO, June 15, 2011 -

CareFusion (NYSE: CFN), a leading global medical technology company,
today announced a five-year exclusive agreement with Spanish company Grifols,
to become the reseller of BlisPack(R), the first robotic system for
identifying, cutting and overwrapping unit doses from blisters in the
hospital pharmacies across Europe, the Middle East, Africa and Asia.*

With this agreement, CareFusion extends to new markets its leading
Pyxis(R) dispensing technologies experience and expertise in medication
management.

The BlisPack system automates the time consuming process of cutting up
blister packs. Pharmaceutical companies generally supply their products to
hospital pharmacies in the same packaging and size format as they do to
retail pharmacies. A medication dose for a patient in a hospital, however, is
tailored to meet individual needs and the original blister packaging needs to
be cut apart and over-wrapped in unit doses under strict professional
supervision guaranteeing total traceability of the process. Health
professionals rely on complete traceability of medication inside the hospital
to help avoid medication and distribution errors.

“As a global leader in medication and supply technologies we are
continuing to focus on end-to-end solutions, from the moment the medication
is delivered to a hospital to the moment that it is given to a patient,” said
Prasanna Parthasarathy, vice president, Global Market Development of Pyxis
Dispensing Technologies at CareFusion. “Blispack with Pyxis technologies
helps improve pharmacy and nursing work flow while supporting the safe
delivery of medications in the hospital. This is in line with our goal to
help prevent medication errors, decrease costs while improving nursing and
pharmacy efficiency.”

“BlisPack is Grifols’ latest contribution in the complex field of
medication safety and hospital logistics, resulting from our continuous
commitment to innovation in the hospital sector,” said Manel Sanchez Maulini,
hospital logistics marketing director, Grifols International. “Since its
official release in July 2010, BlisPack(R) has been successfully introduced
in Grifols core markets for the Hospital Logistics division; among others,
Brazil, Portugal and Spain. With this agreement, CareFusion starts the
worldwide promotion of Grifols patented system, BlisPack. Our relationship
with CareFusion will allow hospitals in many countries to benefit from this
new technology and provide hospital pharmacy professionals with an efficient
and reliable tool to safely dispense and administer medication to patients.”

*Countries where CareFusion will distribute BlisPack(R) include: Algeria,
Australia, Bahamas, Belgium, Canada, Egypt, France, Greece, Israel, Korea,
Kuwait, Malaysia, Morocco, New Zealand, Oman, Puerto Rico, Qatar, Saudi
Arabia, Singapore, South Africa, Switzerland, Tunisia, Turkey and United Arab
Emirates.

About Grifols

Grifols is a Spanish holding company specialized in the pharmaceutical
hospital sector and is present in more than 90 countries. Since 2006, the
company has been listed on the Spanish Stock Exchange (”Mercado Continuo”)
and is part of the Ibex35. Currently it is the first company in the European
sector in plasma derivatives and the fourth in production worldwide. In
upcoming years, the company will strengthen its leadership in the industry as
a vertically integrated company, thanks to recent planned investments. In
terms of raw materials, Grifols has ensured its plasma supply with 80
plasmapheresis centers in the United States and in terms of fractionation,
its plants in Barcelona (Spain) and Los Angeles (United States) will allow
the company to respond to the growing market demand. Nevertheless, the
company is preparing for sustained growth in the following 8 to 10 years and
has launched an ambitious investment plan.

About CareFusion

CareFusion (NYSE: CFN) is a global corporation serving the health care
industry with products and services that help hospitals measurably improve
patient care. The company develops market-leading technologies including
Alaris(R) infusion pumps, Pyxis(R) automated dispensing and patient
identification systems, AirLife(TM), AVEA(R) and LTV(R) series of ventilators
and respiratory products, ChloraPrep(R) skin prep products, MedMined(TM)
services for data mining surveillance, V. Mueller(R) and Snowden-Pencer(R)
surgical instruments and NeuroCare diagnostic products. CareFusion employs
more than 14,000 people across its global operations. More information may be
found at www.carefusion.com.

Media, International, Annika Hjelm of CareFusion - Switzerland, +41-21-556-3106, annika.hjelm at carefusion.com; U.S., Suzanne Hatcher, +1-858-617-2226, suzanne.hatcher at carefusion.com; or Investors, Carol Cox, +1-858-617-2020, carol.cox at carefusion.com